Sara Elizabeth Cosgrove MD
Associate Professor of Medicine, Johns Hopkins University School of Medicine;
Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Are you Dr. Cosgrove?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sara Cosgrove, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Massachusetts. She is affiliated with Johns Hopkins Hospital and is an Associate Professor of Medicine at Johns Hopkins University School of Medicine;.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1998 - 2001
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Baylor College of MedicineClass of 1995
Certifications & Licensure
MD State Medical License 2001 - 2026
MA State Medical License 1998 - 2003
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States.Dariusz A Hareza, Yehudit Bergman, Emily Jacobs, Jennifer Lu, Nancy D Hanson
Antimicrobial Agents and Chemotherapy. 2025-03-05 - How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?Kimberly C Claeys, Patricia J Simner, Tsigereda Tekle, Anthony D Harris, Emily Jacobs
Antimicrobial Agents and Chemotherapy. 2025-02-13 - Methicillin-resistantand Vancomycin Prescribing in the Emergency Department: A Single-center Study Assessing Antibiotic Prescribing.Joshua D Niforatos, Jeremiah S Hinson, Richard E Rothman, Sara E Cosgrove, Kate Dzintars
Journal of the American College of Emergency Physicians Open. 2025-02-01
Press Mentions
Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial InfectionsNovember 21st, 2022- Tighter Controls on Antibiotics Promise to Curb Drug-ResistanceNovember 21st, 2022
- Maximizing Benefits and Minimizing Harms from Antibiotics: Scientific, Regulatory and Clinical Considerations by Dr. Sara Cosgrove November 8, 2022November 8th, 2022
- Join now to see all
Grant Support
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- RFA-CK20-004: Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP HAI & AR)JOHNS HOPKINS UNIVERSITY2021–2026
- Research Training in Microbial DiseasesJOHNS HOPKINS UNIVERSITY1986–2026
